Skip to main content
California Medicine logoLink to California Medicine
. 1970 Oct;113(4):23–38.

Hodgkin's Disease and Other Malignant Lymphomas

Saul A Rosenberg, Henry S Kaplan
PMCID: PMC1501608  PMID: 4991356

Abstract

Systematic studies of the patterns of anatomic distribution, pathways of probable spread, and prognosis of the malignant lymphomas have been greatly aided by the development of new histopathologic classifications and the introduction of more sophisticated and precise diagnostic techniques, such as lymphangiography and laparotomy with splenectomy and retroperitoneal node biopsy. Concomitantly, megavoltage radiotherapy apparatus has made total-lymphoid radiotherapy feasible and practical, and the availability of a widening spectrum of chemotherapeutic agents has ushered in a new era of combination chemotherapy. Collectively, these diagnostic and therapeutic advances have already begun to yield a dramatic improvement in the prognosis of Hodgkin's disease and the other malignant lymphomas.

Full text

PDF
26

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. AISENBERG A. C. Studies on delayed hypersensitivity in Hodgkin's disease. J Clin Invest. 1962 Nov;41:1964–1970. doi: 10.1172/JCI104654. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. BAUM S., BRON K. M., WEXLER L., ABRAMS H. L. LYMPHANGIOGRAPHY, CAVOGRAPHY, AND UROGRAPHY; COMPARATIVE ACCURACY IN THE DIAGNOSIS OF PELVIC AND ABDOMINAL METASTASES. Radiology. 1963 Aug;81:207–218. doi: 10.1148/81.2.207. [DOI] [PubMed] [Google Scholar]
  3. Davidson J. W., Clarke E. A. Influence of modern radiological techniques on clinical staging of malignant lymphomas. Can Med Assoc J. 1968 Dec 21;99(24):1196–1204. [PMC free article] [PubMed] [Google Scholar]
  4. Enright L. P., Trueblood H. W., Nelsen T. S. The surgical diagnosis of abdominal Hodgkin's disease. Surg Gynecol Obstet. 1970 May;130(5):853–858. [PubMed] [Google Scholar]
  5. Ezdinli E. Z., Sokal J. E., Aungst C. W., Kim U., Sandberg A. A. Myeloid leukemia in Hodgkin's disease: chromosomal abnormalities. Ann Intern Med. 1969 Dec;71(6):1097–1104. doi: 10.7326/0003-4819-71-6-1097. [DOI] [PubMed] [Google Scholar]
  6. Franssila K. O., Kalima T. V., Voutlainen A. Histologic classification of Hodgkin's disease. Cancer. 1967 Oct;20(10):1594–1601. doi: 10.1002/1097-0142(196710)20:10<1594::aid-cncr2820201005>3.0.co;2-8. [DOI] [PubMed] [Google Scholar]
  7. Glatstein E., Guernsey J. M., Rosenberg S. A., Kaplan H. S. The value of laparotomy and splenectomy in the staging of Hodgkin's disease. Cancer. 1969 Oct;24(4):709–718. doi: 10.1002/1097-0142(196910)24:4<709::aid-cncr2820240408>3.0.co;2-e. [DOI] [PubMed] [Google Scholar]
  8. Johnson R. E., Kagan A. R., Hafermann M. D., Keyes J. W., Jr Patient tolerance to extended irradiation in Hodgkin's disease. Ann Intern Med. 1969 Jan;70(1):1–6. doi: 10.7326/0003-4819-70-1-1. [DOI] [PubMed] [Google Scholar]
  9. KAPLAN H. S., BAGSHAW M. A., ROSENBERG S. A. PR'ESENTATION DU PROTOCOLE D'ESSAI RADIOTH'ERAPIQUE DES LYMPHOMES MALINS DE L'UNIVERSIT'E DE STANFORD. Nouv Rev Fr Hematol. 1964 Jan-Feb;4:95–100. [PubMed] [Google Scholar]
  10. KAPLAN H. S. The radical radiotherapy of regionally localized Hodgkin's disease. Radiology. 1962 Apr;78:553–561. doi: 10.1148/78.4.553. [DOI] [PubMed] [Google Scholar]
  11. Kaplan H. S. Evidence for a tumoricidal dose level in the radiotherapy of Hodgkin's disease. Cancer Res. 1966 Jun;26(6):1221–1224. [PubMed] [Google Scholar]
  12. Kaplan H. S. Prognostic significance of the relapse-free interval after radiotherapy in Hodgkin's disease. Cancer. 1968 Dec;22(6):1131–1136. doi: 10.1002/1097-0142(196811)22:6<1131::aid-cncr2820220608>3.0.co;2-d. [DOI] [PubMed] [Google Scholar]
  13. Keller A. R., Kaplan H. S., Lukes R. J., Rappaport H. Correlation of histopathology with other prognostic indicators in Hodgkin's disease. Cancer. 1968 Sep;22(3):487–499. doi: 10.1002/1097-0142(196809)22:3<487::aid-cncr2820220302>3.0.co;2-f. [DOI] [PubMed] [Google Scholar]
  14. Lee B. J. Correlation between lymphangiography and clinical status of patients with lymphoma. Cancer Chemother Rep. 1968 Jan;52(1):205–211. [PubMed] [Google Scholar]
  15. Musshoff K., Renemann H., Boutis L., Afkham J. Die extranoduläre Lymphogranulomatose--Diagnose, Therapie und Prognose bei zwei unterschiedlichen Formen des Organbefalls. Ein Beitrag zur Stadieneinteilung des Morbus Hodgkin. Fortschr Geb Rontgenstr Nuklearmed. 1968 Dec;109(6):776–786. [PubMed] [Google Scholar]
  16. Rosenberg S. A. Contribution of lymphangiography to our understanding of lymphoma. Cancer Chemother Rep. 1968 Jan;52(1):213–228. [PubMed] [Google Scholar]
  17. Rosenberg S. A., Kaplan H. S. Evidence for an orderly progression in the spread of Hodgkin's disease. Cancer Res. 1966 Jun;26(6):1225–1231. [PubMed] [Google Scholar]
  18. Seif G. S., Spriggs A. I. Chromosome changes in Hodgkin's disease. J Natl Cancer Inst. 1967 Sep;39(3):557–570. [PubMed] [Google Scholar]

Articles from California Medicine are provided here courtesy of BMJ Publishing Group

RESOURCES